GlassScriptPhysician profile
John Gould
NPI 1215922091
$6,213.90
in general payments reported to CMS, 2019-2025
50 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $550 · 2021: $1,645 · 2022: $1,001 · 2023: $777 · 2024: $405 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,230.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $723.62 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $669.05 | 2021-2025 | |
| Novo Nordisk INC | $652.20 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $443.71 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $321.59 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbott Laboratories | $260.91 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $214.03 | 2019-2025 | |
| Baxter Healthcare | $170.25 | 2022-2023 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.53 | 2019-2025 | Jardiance |
| Pfizer INC. | $152.25 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.37 | 2021-2022 | |
| Esperion Therapeutics, INC. | $147.26 | 2020-2024 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.10 | 2020-2025 | Xifaxan |
| Forte Bio-Pharma LLC | $127.38 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Dexcom, INC. | $125.50 | 2021-2023 | Dexcom G6 Transmitter |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $116.32 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $111.39 | 2020-2021 | |
| Medtronic, INC. | $107.51 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $100.72 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $87.83 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $85.58 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.15 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $79.84 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $77.86 | 2022-2025 | Gvoke Hypopen |
| Astellas Pharma US INC | $77.81 | 2019-2025 | Veozah |
| Amarin Pharma, INC. | $71.07 | 2019-2021 | |
| Theratechnologies INC. | $64.33 | 2025 | Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $61.69 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $58.54 | 2019-2021 | |
| Daiichi Sankyo INC. | $55.83 | 2020-2024 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $49.07 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $47.78 | 2023-2025 | Sunosi, Auvelity |
| Biohaven Pharmaceuticals, INC. | $46.21 | 2021 | |
| Edwards Lifesciences Corporation | $43.93 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $40.64 | 2020-2021 | |
| Inari Medical, INC. | $32.70 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Allergan, INC. | $25.70 | 2019 | |
| Radius Health, INC. | $24.54 | 2020 | |
| Boston Scientific Corporation | $22.10 | 2024 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $21.53 | 2025 | Clottriever Bold Catheter |
| Supernus Pharmaceuticals, INC. | $20.99 | 2022 | |
| Lundbeck LLC | $20.26 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $16.68 | 2023 | Quviviq |
| Ultragenyx Pharmaceutical INC. | $15.98 | 2022 | |
| Sanofi Pasteur INC. | $15.61 | 2019 | |
| Corcept Therapeutics | $15.48 | 2025 | Korlym |
| Shire North American Group INC | $14.76 | 2019 | |
| Mylan Specialty L.P. | $13.36 | 2019 | |
| Hikma Pharmaceuticals USA | $11.36 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.